Empiric Linezolid Treatment Is Associated With Adverse Short-Term Outcomes in Patients With Linezolid-Resistant Staphylococcus epidermidis Bloodstream Infections
Author(s) -
Stephanie A. Folan,
Frank Tverdek,
Jeffrey J. Tarrand,
Samuel A. Shelburne,
Issam Raad,
Victor E. Mulanovich,
Kayleigh Marx,
Samuel L Aitken
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofw194.29
Subject(s) - linezolid , medicine , staphylococcus epidermidis , bloodstream infection , adverse effect , methicillin resistant staphylococcus aureus , staphylococcus aureus , bacteremia , microbiology and biotechnology , intensive care medicine , antibiotics , vancomycin , bacteria , genetics , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom